View in EDS

Author Correction: A µ-opioid receptor superagonist analgesic with minimal adverse effects.

Saved in:
Bibliographic Details
Title: Author Correction: A µ-opioid receptor superagonist analgesic with minimal adverse effects.
Authors: Gomez JL; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Ventriglia EN; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Frangos ZJ; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Sulima A; Drug Design and Synthesis Section, Molecular Targets and Medication Discovery Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Robertson MJ; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA., Sacco MD; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA., Budinich RC; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Giosan IM; Department of Pharmacology, Physiology and Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA., Xie T; Department of Pharmacology, Physiology and Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA., Solis O; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Tischer AE; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Bossert JM; Neurobiology of Relapse Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Caldwell KE; Neurobiology of Relapse Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Bonbrest H; Neurobiology of Relapse Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Essmann A; Departament de Patologia i Terapèutica Experimental, Institut de Neurociències, Universitat de Barcelona, L'Hospitalet de Llobregat, Spain.; Neuropharmacology and Pain Group, Neuroscience Program, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet de Llobregat, Spain., Garçon-Poca ZM; Departament de Patologia i Terapèutica Experimental, Institut de Neurociències, Universitat de Barcelona, L'Hospitalet de Llobregat, Spain.; Neuropharmacology and Pain Group, Neuroscience Program, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet de Llobregat, Spain., Choi S; Behavioral Neuroscience Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Noya MR; Behavioral Neuroscience Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Limiac F; Behavioral Neuroscience Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Arce A; Behavioral Neuroscience Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Glatfelter GC; Designer Drug Research Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Robinson M; Computational Chemistry and Molecular Biophysics Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Chen L; Computational Chemistry and Molecular Biophysics Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Mullarkey AA; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA., Brademan DR; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA., Enten G; Integrative Neurobiology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Dunne W; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Quiroz C; Integrative Neurobiology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Schoenborn I; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Lee CB; Johns Hopkins Drug Discovery, Johns Hopkins School of Medicine, Baltimore, MD, USA.; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA., Rais R; Johns Hopkins Drug Discovery, Johns Hopkins School of Medicine, Baltimore, MD, USA.; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA., Holt DP; Department of Radiology, Johns Hopkins School of Medicine, Baltimore, MD, USA., Dannals RF; Department of Radiology, Johns Hopkins School of Medicine, Baltimore, MD, USA., Shi L; Computational Chemistry and Molecular Biophysics Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Hüttenhain R; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA., Ferré S; Integrative Neurobiology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Kiyatkin E; Behavioral Neuroscience Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Bonaventura J; Departament de Patologia i Terapèutica Experimental, Institut de Neurociències, Universitat de Barcelona, L'Hospitalet de Llobregat, Spain.; Neuropharmacology and Pain Group, Neuroscience Program, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet de Llobregat, Spain., Shaham Y; Neurobiology of Relapse Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Zachariou V; Department of Pharmacology, Physiology and Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA., Baumann MH; Designer Drug Research Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Skiniotis G; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA. georgios.skiniotis@stjude.org.; Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA. georgios.skiniotis@stjude.org.; Department of Structural Biology, St Jude Children's Research Hospital, Memphis, TN, USA. georgios.skiniotis@stjude.org.; Center of Excellence for Structural Cell Biology, St Jude Children's Research Hospital, Memphis, TN, USA. georgios.skiniotis@stjude.org., Rice KC; Drug Design and Synthesis Section, Molecular Targets and Medication Discovery Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA. kennerr@nida.nih.gov., Michaelides M; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA. mike.michaelides@nih.gov.
Source: Nature [Nature] 2026 May; Vol. 653 (8114), pp. E4.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42032332
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: A µ-opioid receptor superagonist analgesic with minimal adverse effects.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gomez+JL%22">Gomez JL</searchLink>; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Ventriglia+EN%22">Ventriglia EN</searchLink>; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Frangos+ZJ%22">Frangos ZJ</searchLink>; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Sulima+A%22">Sulima A</searchLink>; Drug Design and Synthesis Section, Molecular Targets and Medication Discovery Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Robertson+MJ%22">Robertson MJ</searchLink>; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Sacco+MD%22">Sacco MD</searchLink>; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Budinich+RC%22">Budinich RC</searchLink>; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Giosan+IM%22">Giosan IM</searchLink>; Department of Pharmacology, Physiology and Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Xie+T%22">Xie T</searchLink>; Department of Pharmacology, Physiology and Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Solis+O%22">Solis O</searchLink>; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Tischer+AE%22">Tischer AE</searchLink>; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Bossert+JM%22">Bossert JM</searchLink>; Neurobiology of Relapse Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Caldwell+KE%22">Caldwell KE</searchLink>; Neurobiology of Relapse Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Bonbrest+H%22">Bonbrest H</searchLink>; Neurobiology of Relapse Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Essmann+A%22">Essmann A</searchLink>; Departament de Patologia i Terapèutica Experimental, Institut de Neurociències, Universitat de Barcelona, L'Hospitalet de Llobregat, Spain.; Neuropharmacology and Pain Group, Neuroscience Program, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Garçon-Poca+ZM%22">Garçon-Poca ZM</searchLink>; Departament de Patologia i Terapèutica Experimental, Institut de Neurociències, Universitat de Barcelona, L'Hospitalet de Llobregat, Spain.; Neuropharmacology and Pain Group, Neuroscience Program, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Choi+S%22">Choi S</searchLink>; Behavioral Neuroscience Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Noya+MR%22">Noya MR</searchLink>; Behavioral Neuroscience Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Limiac+F%22">Limiac F</searchLink>; Behavioral Neuroscience Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Arce+A%22">Arce A</searchLink>; Behavioral Neuroscience Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Glatfelter+GC%22">Glatfelter GC</searchLink>; Designer Drug Research Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Robinson+M%22">Robinson M</searchLink>; Computational Chemistry and Molecular Biophysics Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Chen+L%22">Chen L</searchLink>; Computational Chemistry and Molecular Biophysics Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Mullarkey+AA%22">Mullarkey AA</searchLink>; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Brademan+DR%22">Brademan DR</searchLink>; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Enten+G%22">Enten G</searchLink>; Integrative Neurobiology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Dunne+W%22">Dunne W</searchLink>; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Quiroz+C%22">Quiroz C</searchLink>; Integrative Neurobiology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Schoenborn+I%22">Schoenborn I</searchLink>; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Lee+CB%22">Lee CB</searchLink>; Johns Hopkins Drug Discovery, Johns Hopkins School of Medicine, Baltimore, MD, USA.; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Rais+R%22">Rais R</searchLink>; Johns Hopkins Drug Discovery, Johns Hopkins School of Medicine, Baltimore, MD, USA.; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Holt+DP%22">Holt DP</searchLink>; Department of Radiology, Johns Hopkins School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Dannals+RF%22">Dannals RF</searchLink>; Department of Radiology, Johns Hopkins School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Shi+L%22">Shi L</searchLink>; Computational Chemistry and Molecular Biophysics Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Hüttenhain+R%22">Hüttenhain R</searchLink>; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ferré+S%22">Ferré S</searchLink>; Integrative Neurobiology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Kiyatkin+E%22">Kiyatkin E</searchLink>; Behavioral Neuroscience Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Bonaventura+J%22">Bonaventura J</searchLink>; Departament de Patologia i Terapèutica Experimental, Institut de Neurociències, Universitat de Barcelona, L'Hospitalet de Llobregat, Spain.; Neuropharmacology and Pain Group, Neuroscience Program, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Shaham+Y%22">Shaham Y</searchLink>; Neurobiology of Relapse Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Zachariou+V%22">Zachariou V</searchLink>; Department of Pharmacology, Physiology and Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Baumann+MH%22">Baumann MH</searchLink>; Designer Drug Research Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Skiniotis+G%22">Skiniotis G</searchLink>; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA. georgios.skiniotis@stjude.org.; Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA. georgios.skiniotis@stjude.org.; Department of Structural Biology, St Jude Children's Research Hospital, Memphis, TN, USA. georgios.skiniotis@stjude.org.; Center of Excellence for Structural Cell Biology, St Jude Children's Research Hospital, Memphis, TN, USA. georgios.skiniotis@stjude.org.<br /><searchLink fieldCode="AU" term="%22Rice+KC%22">Rice KC</searchLink>; Drug Design and Synthesis Section, Molecular Targets and Medication Discovery Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA. kennerr@nida.nih.gov.<br /><searchLink fieldCode="AU" term="%22Michaelides+M%22">Michaelides M</searchLink>; Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA. mike.michaelides@nih.gov.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220410462%22">Nature</searchLink> [Nature] 2026 May; Vol. 653 (8114), pp. E4.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0410462 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-4687 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200280836%22">00280836 </searchLink><i>NLM ISO Abbreviation: </i>Nature <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42032332
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41586-026-10552-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: E4
    Titles:
      – TitleFull: Author Correction: A µ-opioid receptor superagonist analgesic with minimal adverse effects.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gomez JL
      – PersonEntity:
          Name:
            NameFull: Ventriglia EN
      – PersonEntity:
          Name:
            NameFull: Frangos ZJ
      – PersonEntity:
          Name:
            NameFull: Sulima A
      – PersonEntity:
          Name:
            NameFull: Robertson MJ
      – PersonEntity:
          Name:
            NameFull: Sacco MD
      – PersonEntity:
          Name:
            NameFull: Budinich RC
      – PersonEntity:
          Name:
            NameFull: Giosan IM
      – PersonEntity:
          Name:
            NameFull: Xie T
      – PersonEntity:
          Name:
            NameFull: Solis O
      – PersonEntity:
          Name:
            NameFull: Tischer AE
      – PersonEntity:
          Name:
            NameFull: Bossert JM
      – PersonEntity:
          Name:
            NameFull: Caldwell KE
      – PersonEntity:
          Name:
            NameFull: Bonbrest H
      – PersonEntity:
          Name:
            NameFull: Essmann A
      – PersonEntity:
          Name:
            NameFull: Garçon-Poca ZM
      – PersonEntity:
          Name:
            NameFull: Choi S
      – PersonEntity:
          Name:
            NameFull: Noya MR
      – PersonEntity:
          Name:
            NameFull: Limiac F
      – PersonEntity:
          Name:
            NameFull: Arce A
      – PersonEntity:
          Name:
            NameFull: Glatfelter GC
      – PersonEntity:
          Name:
            NameFull: Robinson M
      – PersonEntity:
          Name:
            NameFull: Chen L
      – PersonEntity:
          Name:
            NameFull: Mullarkey AA
      – PersonEntity:
          Name:
            NameFull: Brademan DR
      – PersonEntity:
          Name:
            NameFull: Enten G
      – PersonEntity:
          Name:
            NameFull: Dunne W
      – PersonEntity:
          Name:
            NameFull: Quiroz C
      – PersonEntity:
          Name:
            NameFull: Schoenborn I
      – PersonEntity:
          Name:
            NameFull: Lee CB
      – PersonEntity:
          Name:
            NameFull: Rais R
      – PersonEntity:
          Name:
            NameFull: Holt DP
      – PersonEntity:
          Name:
            NameFull: Dannals RF
      – PersonEntity:
          Name:
            NameFull: Shi L
      – PersonEntity:
          Name:
            NameFull: Hüttenhain R
      – PersonEntity:
          Name:
            NameFull: Ferré S
      – PersonEntity:
          Name:
            NameFull: Kiyatkin E
      – PersonEntity:
          Name:
            NameFull: Bonaventura J
      – PersonEntity:
          Name:
            NameFull: Shaham Y
      – PersonEntity:
          Name:
            NameFull: Zachariou V
      – PersonEntity:
          Name:
            NameFull: Baumann MH
      – PersonEntity:
          Name:
            NameFull: Skiniotis G
      – PersonEntity:
          Name:
            NameFull: Rice KC
      – PersonEntity:
          Name:
            NameFull: Michaelides M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1476-4687
          Numbering:
            – Type: volume
              Value: 653
            – Type: issue
              Value: 8114
          Titles:
            – TitleFull: Nature
              Type: main
ResultId 1